Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Survey of immune tolerance induction for inhibitor elimination in haemophilia A
2008-008378-29Phase 3Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Factor VIII in hemophilia A, sponsored by CHU Saint-Etienne. Primary endpoints: Primary endpoint: success of immune tolerance induction and Primary endpoint: success rate by product type. Started Apr 2009; status: completed.
02
Drugs
Factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2008-008378-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008378-29.